Skip to Content

RTG 300 (Potiga 300 mg)

Generic Name: ezogabine

Pill with imprint RTG 300 is Green, Elliptical / Oval and has been identified as Potiga 300 mg. It is supplied by GlaxoSmithKline.

Potiga is used in the treatment of epilepsy; seizures and belongs to the drug class neuronal potassium channel openers. Risk cannot be ruled out during pregnancy. Potiga 300 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).

Images for RTG 300

Potiga

Generic Name
ezogabine
Imprint
RTG 300
Strength
300 mg
Color
Green
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Neuronal potassium channel openers
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
5 - Some potential for abuse
Labeler / Supplier
GlaxoSmithKline
National Drug Code (NDC)
00173-0813
Inactive Ingredients
croscarmellose sodium, FD&C Blue No. 2, hypromelloses, ferric oxide yellow, soya lecithin, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol, magnesium silicate, titanium dioxide, xanthan gum

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.